223 related articles for article (PubMed ID: 35671831)
1. PhREEPred: Phage Resistance Emergence Prediction Web Tool to Foresee Encapsulated Bacterial Escape from Phage Cocktail Treatment.
Smug BJ; Majkowska-Skrobek G; Drulis-Kawa Z
J Mol Biol; 2022 Jul; 434(14):167670. PubMed ID: 35671831
[TBL] [Abstract][Full Text] [Related]
2. Advantages and limitations of microtiter biofilm assays in the model of antibiofilm activity of Klebsiella phage KP34 and its depolymerase.
Latka A; Drulis-Kawa Z
Sci Rep; 2020 Nov; 10(1):20338. PubMed ID: 33230270
[TBL] [Abstract][Full Text] [Related]
3. Mechanistic Insights into the Capsule-Targeting Depolymerase from a Klebsiella pneumoniae Bacteriophage.
Dunstan RA; Bamert RS; Belousoff MJ; Short FL; Barlow CK; Pickard DJ; Wilksch JJ; Schittenhelm RB; Strugnell RA; Dougan G; Lithgow T
Microbiol Spectr; 2021 Sep; 9(1):e0102321. PubMed ID: 34431721
[TBL] [Abstract][Full Text] [Related]
4. Characterization of four virulent Klebsiella pneumoniae bacteriophages, and evaluation of their potential use in complex phage preparation.
Zurabov F; Zhilenkov E
Virol J; 2021 Jan; 18(1):9. PubMed ID: 33407669
[TBL] [Abstract][Full Text] [Related]
5. Isolation and Characterization of Two
Domingo-Calap P; Beamud B; Mora-Quilis L; González-Candelas F; Sanjuán R
Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32365770
[TBL] [Abstract][Full Text] [Related]
6. Identification of a phage-derived depolymerase specific for KL64 capsule of Klebsiella pneumoniae and its anti-biofilm effect.
Li M; Li P; Chen L; Guo G; Xiao Y; Chen L; Du H; Zhang W
Virus Genes; 2021 Oct; 57(5):434-442. PubMed ID: 34156584
[TBL] [Abstract][Full Text] [Related]
7. A Multiwell-Plate Caenorhabditis elegans Assay for Assessing the Therapeutic Potential of Bacteriophages against Clinical Pathogens.
Manohar P; Loh B; Elangovan N; Loganathan A; Nachimuthu R; Leptihn S
Microbiol Spectr; 2022 Feb; 10(1):e0139321. PubMed ID: 35171008
[TBL] [Abstract][Full Text] [Related]
8. A method for generation phage cocktail with great therapeutic potential.
Gu J; Liu X; Li Y; Han W; Lei L; Yang Y; Zhao H; Gao Y; Song J; Lu R; Sun C; Feng X
PLoS One; 2012; 7(3):e31698. PubMed ID: 22396736
[TBL] [Abstract][Full Text] [Related]
9. Characterization of
Tan D; Zhang Y; Cheng M; Le S; Gu J; Bao J; Qin J; Guo X; Zhu T
Viruses; 2019 Nov; 11(11):. PubMed ID: 31752386
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the therapeutic potential of bacteriophage KpV74 and phage-derived depolymerase (β-glucosidase) against Klebsiella pneumoniae capsular type K2.
Volozhantsev NV; Borzilov AI; Shpirt AM; Krasilnikova VM; Verevkin VV; Denisenko EA; Kombarova TI; Shashkov AS; Knirel YA; Dyatlov IA
Virus Res; 2022 Dec; 322():198951. PubMed ID: 36191686
[TBL] [Abstract][Full Text] [Related]
11. Two T7-like Bacteriophages, K5-2 and K5-4, Each Encodes Two Capsule Depolymerases: Isolation and Functional Characterization.
Hsieh PF; Lin HH; Lin TL; Chen YY; Wang JT
Sci Rep; 2017 Jul; 7(1):4624. PubMed ID: 28676686
[TBL] [Abstract][Full Text] [Related]
12. Klebsiella Phage ΦK64-1 Encodes Multiple Depolymerases for Multiple Host Capsular Types.
Pan YJ; Lin TL; Chen CC; Tsai YT; Cheng YH; Chen YY; Hsieh PF; Lin YT; Wang JT
J Virol; 2017 Mar; 91(6):. PubMed ID: 28077636
[TBL] [Abstract][Full Text] [Related]
13. Bacteriophage therapy for inhibition of multi drug-resistant uropathogenic bacteria: a narrative review.
Chegini Z; Khoshbayan A; Vesal S; Moradabadi A; Hashemi A; Shariati A
Ann Clin Microbiol Antimicrob; 2021 Apr; 20(1):30. PubMed ID: 33902597
[TBL] [Abstract][Full Text] [Related]
14. The therapeutic potential of bacteriophages targeting gram-negative bacteria using Galleria mellonella infection model.
Manohar P; Nachimuthu R; Lopes BS
BMC Microbiol; 2018 Aug; 18(1):97. PubMed ID: 30170558
[TBL] [Abstract][Full Text] [Related]
15. Characterization of a Lytic Bacteriophage and Demonstration of Its Combined Lytic Effect with a K2 Depolymerase on the Hypervirulent
Pertics BZ; Kovács T; Schneider G
Microorganisms; 2023 Mar; 11(3):. PubMed ID: 36985241
[No Abstract] [Full Text] [Related]
16. Characterising the biology of novel lytic bacteriophages infecting multidrug resistant Klebsiella pneumoniae.
Kęsik-Szeloch A; Drulis-Kawa Z; Weber-Dąbrowska B; Kassner J; Majkowska-Skrobek G; Augustyniak D; Lusiak-Szelachowska M; Zaczek M; Górski A; Kropinski AM
Virol J; 2013 Mar; 10():100. PubMed ID: 23537199
[TBL] [Abstract][Full Text] [Related]
17. The Mutation in
Kaszowska M; Majkowska-Skrobek G; Markwitz P; Lood C; Jachymek W; Maciejewska A; Lukasiewicz J; Drulis-Kawa Z
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768992
[No Abstract] [Full Text] [Related]
18. Promises and Pitfalls of In Vivo Evolution to Improve Phage Therapy.
Bull JJ; Levin BR; Molineux IJ
Viruses; 2019 Nov; 11(12):. PubMed ID: 31766537
[TBL] [Abstract][Full Text] [Related]
19. Identification of three capsule depolymerases in a bacteriophage infecting Klebsiella pneumoniae capsular types K7, K20, and K27 and therapeutic application.
Wu JW; Wang JT; Lin TL; Liu YZ; Wu LT; Pan YJ
J Biomed Sci; 2023 May; 30(1):31. PubMed ID: 37210493
[TBL] [Abstract][Full Text] [Related]
20. Isolation of a bacteriophage and its depolymerase specific for K1 capsule of Klebsiella pneumoniae: implication in typing and treatment.
Lin TL; Hsieh PF; Huang YT; Lee WC; Tsai YT; Su PA; Pan YJ; Hsu CR; Wu MC; Wang JT
J Infect Dis; 2014 Dec; 210(11):1734-44. PubMed ID: 25001459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
